Rapporto sulle dimensioni del mercato diagnostico e terapeutico degli esosomi e sull'analisi delle quote | Previsioni 2031

  • Report Code : TIPRE00005514
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 149
Buy Now

Il mercato diagnostico e terapeutico degli esosomi è stato valutato a 41,6,33 milioni di dollari nel 2019 e si prevede che crescerà a un CAGR del 32,2% dal 2020 al 2027 per raggiungere 358,91 milioni di dollari nel 2027.

Gli esosomi sono nano-vescicole che costituiscono proteine, DNA e RNA. Gli esosomi svolgono un ruolo importante nel favorire la comunicazione cellula-cellula durante la diagnosi del cancro. Abbassa la funzione immunitaria del corpo stimolando la morte cellulare programmata delle cellule T citotossiche attivate, che modificano la progressione della neoplasia all'interno del corpo umano. Si prevede che il mercato diagnostico e terapeutico degli esosomi assisterà a un’enorme crescita grazie alla maggiore precisione e ai vantaggi rispetto ai metodi tradizionali di diagnosi e terapia. Tuttavia, le scarse infrastrutture e la mancanza di competenze necessarie per l'isolamento degli esosomi possono ostacolare la crescita del mercato.

Regioni redditizie per il mercato diagnostico e terapeutico degli esosomi


Approfondimenti di mercato

Maggiore precisione e vantaggi rispetto ai metodi diagnostici e terapeutici tradizionali

Gli esosomi sono popolazioni distinte di minuscole vescicole membranose, rilasciate nello spazio extracellulare dalla maggior parte delle cellule, che alla fine si accumulano nella circolazione dei fluidi corporei. Agendo come messaggeri cellulari, svolgono un ruolo nelle funzioni fisiologiche vitali trasportando informazioni tra diversi tipi di cellule. Queste minuscole particelle trasportano gli acidi nucleici cellulari e le proteine dalle cellule ospiti alle cellule bersaglio, che rappresentano l'informazione completa sulle condizioni fisiopatologiche della cellula ospite. Ad esempio, gli esosomi rilasciati dalle cellule tumorali contengono RNA specifici del tumore che possono essere potenzialmente rilevati durante la diagnosi del cancro. Questi esosomi trasportatori possono essere utilizzati anche come biomarcatori nella diagnosi di disturbi neurodegenerativi e metabolici, malattie infettive e di altro tipo. Inoltre, è probabile che la presenza di esosomi nei fluidi corporei come la saliva e l'urina escluda i metodi tradizionali che comportano la raccolta di fluidi corporei invasivi. Pertanto, la crescente enfasi sulla diagnosi clinicamente non invasiva potrebbe guidare l'adozione della diagnosi basata sugli esosomi. e terapie nel settore medico durante il periodo di previsione.

Approfondimenti basati sull'applicazione

In base all'applicazione, la diagnostica e Il mercato terapeutico è ulteriormente segmentato in applicazioni diagnostiche e applicazioni terapeutiche. Il segmento delle applicazioni diagnostiche ha detenuto una quota maggiore di mercato nel 2019 grazie alla crescente consapevolezza dei risultati procedurali forniti dagli esosomi. Ad esempio, nel marzo 2016, Sysmex e JVCKENWOOD hanno lanciato un programma congiunto per lo sviluppo di strumenti diagnostici per la misurazione degli esosomi. Inoltre, si prevede che il segmento diagnostico registrerà un CAGR più elevato nel mercato durante il periodo di previsione. Oltre a ciò, gli esosomi stanno emergendo come promettenti piattaforme terapeutiche grazie al loro ruolo nella proroga della malattia. Tale coinvolgimento degli esosomi può consentirci di inibire la progressione della malattia con l'aiuto di una terapia farmacologica mirata.

Mercato globale diagnostico e terapeutico degli esosomi, per applicazione– 2019 e 2027


Approfondimenti basati sul prodotto

Il mercato diagnostico e terapeutico degli esosomi, per prodotto, è sub segmentato in strumenti, reagenti e software. Nel 2019, il segmento degli strumenti rappresentava la quota maggiore del mercato diagnostico e terapeutico globale degli esosomi a causa della crescente adozione di strumenti per applicazioni diagnostiche. Tuttavia, si stima che il segmento software registrerà il CAGR più elevato sul mercato durante il periodo di previsione. Ciò può essere attribuito alla domanda di piattaforme tecnologiche che offrano integrità, accesso e sicurezza dei dati raccolti in applicazioni diagnostiche e terapeutiche sugli esosomi.

Intuizioni basate sull'utente finale

Il mercato diagnostico e terapeutico degli esosomi, in base all'utente finale, è ulteriormente segmentato in istituti oncologici, ospedali, centri diagnostici e altri. Il segmento degli istituti oncologici ha detenuto la quota maggiore del mercato nel 2019 a causa dell’aumento dei casi di cancro e della domanda di approcci diagnostici avanzati. Gli istituti contro il cancro sono specificatamente dedicati alla ricerca sul cancro, allo sviluppo di farmaci e allo studio sulla gestione del cancro. Si prevede che l’efficienza degli esosomi nella diagnosi del cancro guiderà la crescita del segmento degli istituti oncologici durante il periodo di previsione.

Approfondimenti strategici

La strategia di lancio e espansione dei prodotti viene comunemente adottata dalle aziende per espandere la propria presenza in tutto il mondo e soddisfare la crescente domanda. Questa strategia è più comunemente adottata dagli operatori del mercato al fine di espandere il proprio portafoglio di prodotti.

Gli operatori del mercato che operano nel mercato diagnostico e terapeutico degli esosomi hanno adottato la strategia dell'innovazione del prodotto per soddisfare la mutevole domanda dei clienti in tutto il mondo, che consente inoltre ai giocatori di mantenere il proprio marchio a livello globale.

Mercato diagnostico e terapeutico degli Exosome - Perapplicazione

  • Mercato diagnostico
  • terapeutico


Mercato diagnostico e terapeutico degli esosomi - Per prodotto

  • Strumenti
  • Reagenti
  • Software


Mercato diagnostico e terapeutico degli esosomi - ; Per utente finale

  • Istituti oncologici
  • Ospedali
  • Centri diagnostici
  • Altro

Mercato diagnostico e terapeutico degli esosomi– Per area geografica

  • Nord America
    • Stati Uniti
    • Canada
    • Messico
  • < li>Europa
    • Francia
    • Germania
    • Italia
    • Regno Unito
    • Spagna
    • Resto dell'Europa
  • Asia Pacifico (APAC)
    • Cina
    • India
    • Corea del Sud
    • Giappone
    • Australia
    • Resto dell'APAC
  • Medio Oriente e Asia Africa (MEA)
    • Sudafrica
    • Arabia Saudita
    • EAU
    • Resto del MEA
  • America del Sud (SAM)
    • Brasile
    • Argentina
    • Resto della SAM

Profili aziendali

  • Aethlon Medical, Inc
  • Therapeutic Solutions International, Inc
  • ReNeuron Group plc
  • Immune Therapy Holdings AB
  • Cell Guidance Systems LLC
  • BioRegenerative Sciences
  • Evomic Science LLC
  • NorgenBiotek Corp
  • Exosome Diagnostics, Inc./Bio-Techne
  • MiltenyiBiotec
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is e exosome diagnostic and therapeutic?

Exosome is nanovesicles that constitute proteins, DNA, and RNA. Exosomes play an important role in aiding cell-to-cell communication in the cancer diagnosis. It lowers the body's immune function by stimulating programmed cell death of activated cytotoxic T cells, which modifies neoplasm progression within the human body.

What are the driving factors for the exosome diagnostic and therapeutic market across the globe?

The factors that are driving growth of the market are greater precision and advantages over traditional methods of diagnosis and therapeutics and rise in research and development activities. Moreover, growing preference for noninvasive and novel diagnostic procedures are offering lucrative opportunities for the growth of the market.

Who are the major players in the exosome diagnostic and therapeutic market?

The exosome diagnostic and therapeutic market majorly consists of the players such as Aethlon Medical, Inc., Therapeutic Solutions International, Inc., ReNeuron Group plc, Immune Therapy Holdings AB, Cell Guidance Systems LLC, BioRegenerative Sciences, Evomic Science LLC, Norgen Biotek Corp., Exosome Diagnostics, Inc./Bio-Techne, and Miltenyi Biotec among others.

The List of Companies - Exosome Diagnostic and Treatment Market

  1. Aethlon Medical, Inc
  2. Therapeutic Solutions International, Inc
  3. ReNeuron Group plc
  4. Immune Therapy Holdings AB
  5. Cell Guidance Systems LLC
  6. BioRegenerative Sciences
  7. Evomic Science LLC
  8. Norgen Biotek Corp
  9. Exosome Diagnostics, Inc./Bio-Techne
  10. Miltenyi Biotech

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports